The prescribing of direct-acting antiviral (DAA) therapy for people with hepatitis C (HCV) has shifted from gastroenterologists to GPs since the drugs were made available on the PBS in 2016, new figures show. While gastroenterologists and other specialists initially treated a high proportion of people with HCV when DAAs were first reimbursed, the trend has ...
Prescribing of DAAs shift from specialists to GPs for people with hepatitis C
By Michael Woodhead
11 Aug 2021